Apple
AAPL
Oracle
ORCL
Adobe
ADBE
Ecopetrol
EC
D.R. Horton
DHI
US Stock MarketDetailed Quotes
PTGX Protagonist Therapeutics
- 39.020
- -1.670-4.10%
Close Dec 18 16:00 ET
- 40.000
- +0.980+2.51%
Pre 07:06 ET
2.33BMarket Cap14.24P/E (TTM)
41.180High38.615Low636.73KVolume40.710Open40.690Pre Close25.30MTurnover1.34%Turnover RatioLossP/E (Static)59.60MShares48.89052wk High4.37P/B1.86BFloat Cap21.43052wk Low--Dividend TTM47.67MShs Float50.540Historical High--Div YieldTTM6.30%Amplitude4.470Historical Low39.730Avg Price1Lot Size
About Protagonist Therapeutics Company
Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943. The company was founded by Mark L. Smythe on August 22, 2006 and is headquartered in Newark, CA.
Company Profile
SymbolPTGX
Company NameProtagonist Therapeutics
Listing DateAug 11, 2016
Issue Price12.00
Founded2006
CEODr. Dinesh V. Patel, PhD
MarketNASDAQ
Employees112
Fiscal Year Ends12-31
Address7707 Gateway Boulevard,Suite 140
CityNewark
ProvinceCalifornia
CountryUnited States of America
Zip Code94560-1160
Phone1-510-474-0170
Company Executives
- Name
- Position
- Salary
- Dr. Dinesh V. Patel, PhD
- Director, President and Chief Executive Officer
- 7.07M
- Dr. Arturo Molina, M.D.
- Chief Medical Officer
- --
- Dr. Suneel Gupta, PhD
- Chief Development Officer
- 2.22M
- Asif Ali
- Executive Vice President, Principal Accounting Officer and Chief Financial Officer
- 1.40M
- Dr. Harold E. Selick, PhD
- Chairman of the Board
- 395.27K
- Sarah A. O’Dowd
- Independent Director
- 341.52K
- Bryan Giraudo
- Independent Director
- 356.52K
- William D. Waddill
- Independent Director
- 364.02K
- Dr. Lewis T. Willia M.D.,PhD
- Independent Director
- 351.52K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.